• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

敲除 GluN2D 型谷氨酸受体后,氯胺酮对内侧前额叶皮层神经元自发性兴奋性突触后电流的作用被消除。

Abolished ketamine effects on the spontaneous excitatory postsynaptic current of medial prefrontal cortex neurons in GluN2D knockout mice.

机构信息

School of Biological Sciences, Seoul National University, 1, Gwanak-ro, Gwanak-gu, Seoul, 08826, Korea.

Addictive Substance Project, Tokyo Metropolitan Institute of Medical Science, 2- 1-6 Kamikitazawa, Setagaya-ku, Tokyo, 156-8506, Japan.

出版信息

Mol Brain. 2021 Dec 7;14(1):174. doi: 10.1186/s13041-021-00883-7.

DOI:10.1186/s13041-021-00883-7
PMID:34876180
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8650376/
Abstract

Ketamine, a non-competitive antagonist of the N-methyl-D-aspartate receptor (NMDAR), generates a rapidly-acting antidepressant effect. It exerts psychomimetic effects, yet demands a further investigation of its mechanism. Previous research showed that ketamine did no longer promote hyperlocomotion in GluN2D knockout (KO) mice, which is a subunit of NMDAR. In the present study, we tested whether GluN2D-containing NMDARs participate in the physiological changes in the medial prefrontal cortex (mPFC) triggered by ketamine. Sub-anesthetic dose of ketamine (25 mg/kg) elevated the frequency of spontaneous excitatory postsynaptic currents (sEPSC) in wild-type (WT) mice, but not in GluN2D KO mice, 1 h after the injection. The amplitude of sEPSC and paired-pulse ratio (PPR) were unaltered by ketamine in both WT and GluN2D KO mice. These findings suggest that GluN2D-containing NMDARs might play a role in the ketamine-mediated changes in glutamatergic neurons in mPFC and, presumably, in ketamine-induced hyperlocomotion.

摘要

氯胺酮是一种 N-甲基-D-天冬氨酸受体(NMDAR)的非竞争性拮抗剂,能迅速产生抗抑郁作用。它具有致幻作用,但需要进一步研究其作用机制。先前的研究表明,氯胺酮不再促进 NMDAR 亚基 GluN2D 敲除(KO)小鼠的过度活跃,在本研究中,我们测试了 GluN2D 包含的 NMDAR 是否参与氯胺酮引发的内侧前额叶皮层(mPFC)的生理变化。亚麻醉剂量的氯胺酮(25mg/kg)在注射后 1 小时,可增加野生型(WT)小鼠而非 GluN2D KO 小鼠的自发兴奋性突触后电流(sEPSC)频率。sEPSC 的幅度和成对脉冲比(PPR)在 WT 和 GluN2D KO 小鼠中均未受氯胺酮影响。这些发现表明,GluN2D 包含的 NMDAR 可能在氯胺酮介导的 mPFC 谷氨酸能神经元变化中发挥作用,可能在氯胺酮诱导的过度活跃中发挥作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f67/8650376/73902c564a25/13041_2021_883_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f67/8650376/73902c564a25/13041_2021_883_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f67/8650376/73902c564a25/13041_2021_883_Fig1_HTML.jpg

相似文献

1
Abolished ketamine effects on the spontaneous excitatory postsynaptic current of medial prefrontal cortex neurons in GluN2D knockout mice.敲除 GluN2D 型谷氨酸受体后,氯胺酮对内侧前额叶皮层神经元自发性兴奋性突触后电流的作用被消除。
Mol Brain. 2021 Dec 7;14(1):174. doi: 10.1186/s13041-021-00883-7.
2
GluN2D N-Methyl-d-Aspartate Receptor Subunit Contribution to the Stimulation of Brain Activity and Gamma Oscillations by Ketamine: Implications for Schizophrenia.谷氨酸N2D型N-甲基-D-天冬氨酸受体亚基对氯胺酮刺激脑活动和γ振荡的作用:对精神分裂症的启示
J Pharmacol Exp Ther. 2016 Mar;356(3):702-11. doi: 10.1124/jpet.115.230391. Epub 2015 Dec 16.
3
Role of the NMDA receptor GluN2D subunit in the expression of ketamine-induced behavioral sensitization and region-specific activation of neuronal nitric oxide synthase.N-甲基-D-天冬氨酸受体GluN2D亚基在氯胺酮诱导的行为敏化表达及神经元型一氧化氮合酶区域特异性激活中的作用
Neurosci Lett. 2016 Jan 1;610:48-53. doi: 10.1016/j.neulet.2015.10.049. Epub 2015 Oct 28.
4
Sevoflurane acts as an antidepressant by suppression of GluN2D-containing NMDA receptors on interneurons.七氟醚通过抑制中间神经元上含 GluN2D 的 NMDA 受体发挥抗抑郁作用。
Br J Pharmacol. 2024 Sep;181(18):3483-3502. doi: 10.1111/bph.16420. Epub 2024 May 23.
5
Cognitive Impairment That Is Induced by (R)-Ketamine Is Abolished in NMDA GluN2D Receptor Subunit Knockout Mice.(R)-氯胺酮诱导的认知障碍在 NMDA 谷氨酸受体 2D 亚单位敲除小鼠中被消除。
Int J Neuropsychopharmacol. 2019 Jul 1;22(7):449-452. doi: 10.1093/ijnp/pyz025.
6
GluN2D-Containing N-methyl-d-Aspartate Receptors Mediate Synaptic Transmission in Hippocampal Interneurons and Regulate Interneuron Activity.含GluN2D的N-甲基-D-天冬氨酸受体介导海马中间神经元的突触传递并调节中间神经元活性。
Mol Pharmacol. 2016 Dec;90(6):689-702. doi: 10.1124/mol.116.105130. Epub 2016 Sep 13.
7
Role of NMDA receptor GluN2D subunit in the antidepressant effects of enantiomers of ketamine.N-甲基-D-天冬氨酸受体GluN2D亚基在氯胺酮对映体抗抑郁作用中的作用
J Pharmacol Sci. 2017 Nov;135(3):138-140. doi: 10.1016/j.jphs.2017.11.001. Epub 2017 Nov 10.
8
NMDA receptors containing GluN2C and GluN2D subunits have opposing roles in modulating neuronal oscillations; potential mechanism for bidirectional feedback.含 GluN2C 和 GluN2D 亚基的 NMDA 受体在调节神经元振荡方面具有相反的作用;双向反馈的潜在机制。
Brain Res. 2020 Jan 15;1727:146571. doi: 10.1016/j.brainres.2019.146571. Epub 2019 Nov 28.
9
Ketamine Administration During the Second Postnatal Week Alters Synaptic Properties of Fast-Spiking Interneurons in the Medial Prefrontal Cortex of Adult Mice.出生后第二周给予氯胺酮会改变成年小鼠内侧前额叶皮质中快速放电中间神经元的突触特性。
Cereb Cortex. 2016 Mar;26(3):1117-29. doi: 10.1093/cercor/bhu293. Epub 2014 Dec 4.
10
Loss of the sustained antidepressant-like effect of (2R,6R)-hydroxynorketamine in NMDA receptor GluN2D subunit knockout mice.NMDA 受体 GluN2D 亚单位敲除小鼠中(2R,6R)-羟基去甲氯胺酮抗抑郁样作用的丧失。
J Pharmacol Sci. 2024 Mar;154(3):203-208. doi: 10.1016/j.jphs.2024.01.008. Epub 2024 Jan 26.

引用本文的文献

1
Ketamine and the neurobiology of depression: Toward next-generation rapid-acting antidepressant treatments.氯胺酮与抑郁症的神经生物学:迈向新一代快速抗抑郁治疗方法。
Proc Natl Acad Sci U S A. 2023 Dec 5;120(49):e2305772120. doi: 10.1073/pnas.2305772120. Epub 2023 Nov 27.
2
Non-Opioid Anesthetics Addiction: A Review of Current Situation and Mechanism.非阿片类麻醉药成瘾:现状与机制综述
Brain Sci. 2023 Aug 30;13(9):1259. doi: 10.3390/brainsci13091259.

本文引用的文献

1
Deep posteromedial cortical rhythm in dissociation.分离状态下的深部后内侧皮质节律。
Nature. 2020 Oct;586(7827):87-94. doi: 10.1038/s41586-020-2731-9. Epub 2020 Sep 16.
2
GluN2D-mediated excitatory drive onto medial prefrontal cortical PV+ fast-spiking inhibitory interneurons.谷氨酸能 N-甲基-D-天冬氨酸受体 2D 亚基(GluN2D)介导的兴奋性传入投射到内侧前额叶皮层表达蛋白 vimentin(PV+)的快速放电抑制性中间神经元上。
PLoS One. 2020 Jun 4;15(6):e0233895. doi: 10.1371/journal.pone.0233895. eCollection 2020.
3
Increasing doses of ketamine curtail antidepressant responses and suppress associated synaptic signaling pathways.
增加氯胺酮剂量会抑制抗抑郁反应并抑制相关的突触信号通路。
Behav Brain Res. 2020 Feb 17;380:112378. doi: 10.1016/j.bbr.2019.112378. Epub 2019 Nov 21.
4
GABA interneurons are the cellular trigger for ketamine's rapid antidepressant actions.GABA 中间神经元是氯胺酮快速抗抑郁作用的细胞触发因素。
J Clin Invest. 2020 Mar 2;130(3):1336-1349. doi: 10.1172/JCI130808.
5
Cognitive Impairment That Is Induced by (R)-Ketamine Is Abolished in NMDA GluN2D Receptor Subunit Knockout Mice.(R)-氯胺酮诱导的认知障碍在 NMDA 谷氨酸受体 2D 亚单位敲除小鼠中被消除。
Int J Neuropsychopharmacol. 2019 Jul 1;22(7):449-452. doi: 10.1093/ijnp/pyz025.
6
Transcription-independent expression of PKMζ in the anterior cingulate cortex contributes to chronically maintained neuropathic pain.转录非依赖性的 PKMζ 在扣带前皮质中的表达导致慢性维持性神经病理性疼痛。
Mol Pain. 2018 Jan-Dec;14:1744806918783943. doi: 10.1177/1744806918783943.
7
Role of NMDA receptor GluN2D subunit in the antidepressant effects of enantiomers of ketamine.N-甲基-D-天冬氨酸受体GluN2D亚基在氯胺酮对映体抗抑郁作用中的作用
J Pharmacol Sci. 2017 Nov;135(3):138-140. doi: 10.1016/j.jphs.2017.11.001. Epub 2017 Nov 10.
8
Role of the NMDA receptor GluN2D subunit in the expression of ketamine-induced behavioral sensitization and region-specific activation of neuronal nitric oxide synthase.N-甲基-D-天冬氨酸受体GluN2D亚基在氯胺酮诱导的行为敏化表达及神经元型一氧化氮合酶区域特异性激活中的作用
Neurosci Lett. 2016 Jan 1;610:48-53. doi: 10.1016/j.neulet.2015.10.049. Epub 2015 Oct 28.
9
GluN2B-containing NMDA receptors regulate depression-like behavior and are critical for the rapid antidepressant actions of ketamine.含GluN2B的N-甲基-D-天冬氨酸受体调节抑郁样行为,并且对氯胺酮的快速抗抑郁作用至关重要。
Elife. 2014 Oct 23;3:e03581. doi: 10.7554/eLife.03581.
10
Rapid-acting glutamatergic antidepressants: the path to ketamine and beyond.快速作用的谷氨酸抗抑郁药:从氯胺酮到其他药物的探索之路。
Biol Psychiatry. 2013 Jun 15;73(12):1133-41. doi: 10.1016/j.biopsych.2013.03.026.